Mark Fitzgerald - Concepedia

Author

Mark Fitzgerald

Also Known As

Christina Saunders, Christina T. Saunders, Elizabeth O. Fagbodun, Fitzgerald, M., Fitzgerald, M.; Picard, R.R.; Silver, R.N., Fitzgerald, Mark, Flávia R. Machado, M Fitzgerald, M. Fitzgerald, MARK FITZGERALD

Publications

7.2K

Citations

H-Index

Concepts

All Affiliations

University of Oxford Berry & Associates (United States)Queen's University Belfast University of Pittsburgh University of KwaZulu-Natal

About

Mark Fitzgerald is an author at University of Oxford specializing in engineering, chemistry, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Engineering	10	10	327
2	Medicine	7	8	4.4K
3	Natural Sciences	3	3	76
4	Public Health	3	3	489
5	Social Sciences	3	3	3.3K

Mark Fitzgerald

Publications

5.7K

Citations

H-Index

Page 1

	Year	Citations
Improved Assessment of Significant Activation in Functional Magnetic Resonance Imaging (fMRI): Use of a Cluster‐Size Threshold Steven D. Forman, Jonathan D. Cohen, Mark Fitzgerald, Magnetic Resonance in Medicine NeuropsychologyFmri StudiesBrain MappingStatistical PowerFunctional Neuroimaging	1995	3.2K
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial Christopher Butler, Richard Hobbs, Oghenekome Gbinigie, The Lancet Long CovidTreatment And PreventionCovid-19 PandemicAdverse OutcomesAntiviral Therapy	2022	391
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial Christopher Butler, Jienchi Dorward, Ly‐Mee Yu, The Lancet	2021	306
Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial Ly‐Mee Yu, Mona Bafadhel, Jienchi Dorward, The Lancet EpidemiologyRespiratory DiseasesMedicineRespiratory InfectionInfectious Respiratory Disease	2021	302
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19 Hesham Abdelhady, Marwa Abdelrazik, Zakee Abdi, JAMA	2021	208
Effect of Antiplatelet Therapy on Survival and Organ Support–Free Days in Critically Ill Patients With COVID-19 Simin Florescu, Delia Stanciu, Mihaela Zaharia, JAMA	2022	147
Improved image registration by using fourier interpolation William F. Eddyy, Mark Fitzgerald, Douglas C. Noll Magnetic Resonance in Medicine	1996	143
Long-term (180-Day) Outcomes in Critically Ill Patients With COVID-19 in the REMAP-CAP Randomized Clinical Trial Simin Florescu, Delia Stanciu, Mihaela Zaharia, JAMA	2022	133
Canonical transition probabilities for adaptive Metropolis simulation Mark Fitzgerald, Richard R. Picard, R. N. Silver Europhysics Letters (EPL) EngineeringData ScienceStatistical EstimatorsUncertainty QuantificationEntropy	1999	126
Monte Carlo Transition Dynamics and Variance Reduction Mark Fitzgerald, Richard R. Picard, R. N. Silver Journal of Statistical Physics	2000	94

Page 1